227 related articles for article (PubMed ID: 31802236)
1. Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.
Liu APY; Gudenas B; Lin T; Orr BA; Klimo P; Kumar R; Bouffet E; Gururangan S; Crawford JR; Kellie SJ; Chintagumpala M; Fisher MJ; Bowers DC; Hassall T; Indelicato DJ; Onar-Thomas A; Ellison DW; Boop FA; Merchant TE; Robinson GW; Northcott PA; Gajjar A
Acta Neuropathol; 2020 Feb; 139(2):259-271. PubMed ID: 31802236
[TBL] [Abstract][Full Text] [Related]
2. Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study.
Liu APY; Li BK; Pfaff E; Gudenas B; Vasiljevic A; Orr BA; Dufour C; Snuderl M; Karajannis MA; Rosenblum MK; Hwang EI; Ng HK; Hansford JR; Szathmari A; Faure-Conter C; Merchant TE; Levine M; Bouvier N; von Hoff K; Mynarek M; Rutkowski S; Sahm F; Kool M; Hawkins C; Onar-Thomas A; Robinson GW; Gajjar A; Pfister SM; Bouffet E; Northcott PA; Jones DTW; Huang A
Acta Neuropathol; 2021 May; 141(5):771-785. PubMed ID: 33619588
[TBL] [Abstract][Full Text] [Related]
3. Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials.
Liu APY; Dhanda SK; Lin T; Sioson E; Vasilyeva A; Gudenas B; Tatevossian RG; Jia S; Neale G; Bowers DC; Hassall T; Partap S; Crawford JR; Chintagumpala M; Bouffet E; McCowage G; Broniscer A; Qaddoumi I; Armstrong G; Wright KD; Upadhyaya SA; Vinitsky A; Tinkle CL; Lucas J; Chiang J; Indelicato DJ; Sanders R; Klimo P; Boop FA; Merchant TE; Ellison DW; Northcott PA; Orr BA; Zhou X; Onar-Thomas A; Gajjar A; Robinson GW
Acta Neuropathol; 2022 Oct; 144(4):733-746. PubMed ID: 35982322
[TBL] [Abstract][Full Text] [Related]
4. Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study.
Li BK; Vasiljevic A; Dufour C; Yao F; Ho BLB; Lu M; Hwang EI; Gururangan S; Hansford JR; Fouladi M; Nobusawa S; Laquerriere A; Delisle MB; Fangusaro J; Forest F; Toledano H; Solano-Paez P; Leary S; Birks D; Hoffman LM; Szathmari A; Faure-Conter C; Fan X; Catchpoole D; Zhou L; Schultz KAP; Ichimura K; Gauchotte G; Jabado N; Jones C; Loussouarn D; Mokhtari K; Rousseau A; Ziegler DS; Tanaka S; Pomeroy SL; Gajjar A; Ramaswamy V; Hawkins C; Grundy RG; Hill DA; Bouffet E; Huang A; Jouvet A
Acta Neuropathol; 2020 Feb; 139(2):223-241. PubMed ID: 31820118
[TBL] [Abstract][Full Text] [Related]
5. Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations.
Pfaff E; Aichmüller C; Sill M; Stichel D; Snuderl M; Karajannis MA; Schuhmann MU; Schittenhelm J; Hasselblatt M; Thomas C; Korshunov A; Rhizova M; Wittmann A; Kaufhold A; Iskar M; Ketteler P; Lohmann D; Orr BA; Ellison DW; von Hoff K; Mynarek M; Rutkowski S; Sahm F; von Deimling A; Lichter P; Kool M; Zapatka M; Pfister SM; Jones DTW
Acta Neuropathol; 2020 Feb; 139(2):243-257. PubMed ID: 31768671
[TBL] [Abstract][Full Text] [Related]
6. Pineoblastoma in children less than six years of age: The Head Start I, II, and III experience.
Abdelbaki MS; Abu-Arja MH; Davidson TB; Fangusaro JR; Stanek JR; Dunkel IJ; Dhall G; Gardner SL; Finlay JL
Pediatr Blood Cancer; 2020 Jun; 67(6):e28252. PubMed ID: 32187454
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of age-dependent treatment strategies for children and young adults with pineoblastoma: analysis of pooled European Society for Paediatric Oncology (SIOP-E) and US Head Start data.
Mynarek M; Pizer B; Dufour C; van Vuurden D; Garami M; Massimino M; Fangusaro J; Davidson T; Gil-da-Costa MJ; Sterba J; Benesch M; Gerber N; Juhnke BO; Kwiecien R; Pietsch T; Kool M; Clifford S; Ellison DW; Giangaspero F; Wesseling P; Gilles F; Gottardo N; Finlay JL; Rutkowski S; von Hoff K
Neuro Oncol; 2017 Apr; 19(4):576-585. PubMed ID: 28011926
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes and patterns of failure in pineoblastoma: a 30-year, single-institution retrospective review.
Farnia B; Allen PK; Brown PD; Khatua S; Levine NB; Li J; Penas-Prado M; Mahajan A; Ghia AJ
World Neurosurg; 2014 Dec; 82(6):1232-41. PubMed ID: 25045788
[TBL] [Abstract][Full Text] [Related]
9. Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.
Robinson GW; Rudneva VA; Buchhalter I; Billups CA; Waszak SM; Smith KS; Bowers DC; Bendel A; Fisher PG; Partap S; Crawford JR; Hassall T; Indelicato DJ; Boop F; Klimo P; Sabin ND; Patay Z; Merchant TE; Stewart CF; Orr BA; Korbel JO; Jones DTW; Sharma T; Lichter P; Kool M; Korshunov A; Pfister SM; Gilbertson RJ; Sanders RP; Onar-Thomas A; Ellison DW; Gajjar A; Northcott PA
Lancet Oncol; 2018 Jun; 19(6):768-784. PubMed ID: 29778738
[TBL] [Abstract][Full Text] [Related]
10. Histopathology and molecular pathology of pediatric pineal parenchymal tumors.
Vasiljevic A
Childs Nerv Syst; 2023 Sep; 39(9):2273-2284. PubMed ID: 35972537
[TBL] [Abstract][Full Text] [Related]
11. Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome.
Raleigh DR; Solomon DA; Lloyd SA; Lazar A; Garcia MA; Sneed PK; Clarke JL; McDermott MW; Berger MS; Tihan T; Haas-Kogan DA
Neuro Oncol; 2017 Jan; 19(1):78-88. PubMed ID: 27282397
[TBL] [Abstract][Full Text] [Related]
12. Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma.
Snuderl M; Kannan K; Pfaff E; Wang S; Stafford JM; Serrano J; Heguy A; Ray K; Faustin A; Aminova O; Dolgalev I; Stapleton SL; Zagzag D; Chiriboga L; Gardner SL; Wisoff JH; Golfinos JG; Capper D; Hovestadt V; Rosenblum MK; Placantonakis DG; LeBoeuf SE; Papagiannakopoulos TY; Chavez L; Ahsan S; Eberhart CG; Pfister SM; Jones DTW; Karajannis MA
Nat Commun; 2018 Jul; 9(1):2868. PubMed ID: 30030436
[TBL] [Abstract][Full Text] [Related]
13. Two cases of pineal anlage tumor with molecular analysis.
Scherpelz KP; Crotty EE; Paulson VA; Lockwood CM; Leary SES; Ellenbogen RG; Lee A; Ermoian RP; Vitanza NA; Cole BL
Pediatr Blood Cancer; 2022 Apr; 69(4):e29596. PubMed ID: 35129878
[TBL] [Abstract][Full Text] [Related]
14. Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma.
Lee JC; Mazor T; Lao R; Wan E; Diallo AB; Hill NS; Thangaraj N; Wendelsdorf K; Samuel D; Kline CN; Banerjee A; Auguste K; Raffel C; Gupta N; Berger M; Raleigh DR; Shai A; Phillips JJ; Bollen AW; Tihan T; Perry A; Costello J; Solomon DA
Acta Neuropathol; 2019 May; 137(5):851-854. PubMed ID: 30877433
[No Abstract] [Full Text] [Related]
15. Long term outcome of adolescent and adult patients with pineal parenchymal tumors treated with fractionated radiotherapy between 1982 and 2003--a single institution's experience.
Stoiber EM; Schaible B; Herfarth K; Schulz-Ertner D; Huber PE; Debus J; Oertel S
Radiat Oncol; 2010 Dec; 5():122. PubMed ID: 21184689
[TBL] [Abstract][Full Text] [Related]
16. Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.
Liu APY; Gudenas B; Lin T; Orr BA; Klimo P; Kumar R; Bouffet E; Gururangan S; Crawford JR; Kellie SJ; Chintagumpala M; Fisher MJ; Bowers DC; Hassall T; Indelicato DJ; Onar-Thomas A; Ellison DW; Boop FA; Merchant TE; Robinson GW; Northcott PA; Gajjar A
Acta Neuropathol; 2020 Feb; 139(2):273-275. PubMed ID: 31865440
[TBL] [Abstract][Full Text] [Related]
17. Pineoblastoma is uniquely tolerant of mutually exclusive loss of DICER1, DROSHA or DGCR8.
de Kock L; Rivera B; Foulkes WD
Acta Neuropathol; 2020 Jun; 139(6):1115-1118. PubMed ID: 32124011
[No Abstract] [Full Text] [Related]
18. Retrospective Analysis of the Clinical Characteristics, Therapeutic Aspects, and Prognostic Factors of 18 Cases of Childhood Pineoblastoma.
Tian Y; Liu R; Qin J; Wang J; Ma Z; Gong J; Li C
World Neurosurg; 2018 Aug; 116():e162-e168. PubMed ID: 29709740
[TBL] [Abstract][Full Text] [Related]
19. Childhood pineoblastoma: experiences from the prospective multicenter trials HIT-SKK87, HIT-SKK92 and HIT91.
Hinkes BG; von Hoff K; Deinlein F; Warmuth-Metz M; Soerensen N; Timmermann B; Mittler U; Urban C; Bode U; Pietsch T; Schlegel PG; Kortmann RD; Kuehl J; Rutkowski S
J Neurooncol; 2007 Jan; 81(2):217-23. PubMed ID: 16941074
[TBL] [Abstract][Full Text] [Related]
20. Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy.
Friedrich C; von Bueren AO; von Hoff K; Gerber NU; Ottensmeier H; Deinlein F; Benesch M; Kwiecien R; Pietsch T; Warmuth-Metz M; Faldum A; Kuehl J; Kortmann RD; Rutkowski S
Neuro Oncol; 2013 Feb; 15(2):224-34. PubMed ID: 23223339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
